ofloxacin has been researched along with Pain in 13 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This multinational, multicentre, prospective, randomised, double blind, parallel group, non-inferiority study compared the efficacy and safety of moxifloxacin monotherapy with ofloxacin plus metronidazole in women with uncomplicated pelvic inflammatory disease." | 9.12 | Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. ( Alefelder, M; Arvis, P; Cronjé, HS; Kureishi, A; Paszkowski, T; Rakoczi, I; Reimnitz, P; Ross, JD; Vildaite, D, 2006) |
| "This study compared the efficacy, safety, and ear-pain resolution of once-daily ofloxacin otic solution (0." | 9.12 | Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with ( Schwartz, RH, 2006) |
| "This multinational, multicentre, prospective, randomised, double blind, parallel group, non-inferiority study compared the efficacy and safety of moxifloxacin monotherapy with ofloxacin plus metronidazole in women with uncomplicated pelvic inflammatory disease." | 5.12 | Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. ( Alefelder, M; Arvis, P; Cronjé, HS; Kureishi, A; Paszkowski, T; Rakoczi, I; Reimnitz, P; Ross, JD; Vildaite, D, 2006) |
| "This study compared the efficacy, safety, and ear-pain resolution of once-daily ofloxacin otic solution (0." | 5.12 | Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with ( Schwartz, RH, 2006) |
| " A dosage of 750 mg q." | 1.34 | Safety of prolonged high-dose levofloxacin therapy for bone infections. ( Beltrand, E; Caillaux, M; Dehecq, C; Legout, L; Loïez, C; Migaud, H; Mouton, Y; Poissy, J; Senneville, E; Valette, M; Yazdanpanah, Y, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Küçükgüzel, SG | 1 |
| Küçükgüzel, I | 1 |
| Tatar, E | 1 |
| Rollas, S | 1 |
| Sahin, F | 1 |
| Güllüce, M | 1 |
| De Clercq, E | 1 |
| Kabasakal, L | 1 |
| Huruba, M | 1 |
| Farcas, A | 1 |
| Leucuta, DC | 1 |
| Bucsa, C | 1 |
| Sipos, M | 1 |
| Mogosan, C | 1 |
| Woods, JL | 1 |
| Scurlock, AM | 1 |
| Hensel, DJ | 1 |
| Panas, M | 1 |
| Karadima, G | 1 |
| Kalfakis, N | 1 |
| Vassilopoulos, D | 1 |
| Schuette, W | 1 |
| Nagel, S | 1 |
| von Weikersthal, LF | 1 |
| Pabst, S | 1 |
| Schumann, C | 1 |
| Deuss, B | 1 |
| Salm, T | 1 |
| Roscher, K | 1 |
| Dickgreber, N | 1 |
| Onoe, H | 1 |
| Yotsu, RR | 1 |
| Nakanaga, K | 1 |
| Hoshino, Y | 1 |
| Ishii, N | 1 |
| Takeuchi, T | 1 |
| Ross, JD | 1 |
| Cronjé, HS | 1 |
| Paszkowski, T | 1 |
| Rakoczi, I | 1 |
| Vildaite, D | 1 |
| Kureishi, A | 1 |
| Alefelder, M | 1 |
| Arvis, P | 1 |
| Reimnitz, P | 1 |
| Schwartz, RH | 1 |
| Senneville, E | 1 |
| Poissy, J | 1 |
| Legout, L | 1 |
| Dehecq, C | 1 |
| Loïez, C | 1 |
| Valette, M | 1 |
| Beltrand, E | 1 |
| Caillaux, M | 1 |
| Mouton, Y | 1 |
| Migaud, H | 1 |
| Yazdanpanah, Y | 1 |
| Listernick, R | 1 |
| Hennenfent, BR | 1 |
| Feliciano, AE | 1 |
| Nuño Mateo, FJ | 1 |
| Noval Menéndez, J | 1 |
| Suárez, M | 1 |
| Guinea, O | 1 |
| Roberts, C | 1 |
4 trials available for ofloxacin and Pain
| Article | Year |
|---|---|
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chem | 2011 |
Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Double-Blind Method; Drug Therapy | 2006 |
Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with
Topics: Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Double-Blind Method; Drug A | 2006 |
Comparison of the ocular comfort of ofloxacin 0.3% ophthalmic solution and lubricant eye drops.
Topics: Adult; Anti-Infective Agents; Eye; Eye Diseases; Female; Humans; Lubrication; Male; Ofloxacin; Ophth | 2002 |
9 other studies available for ofloxacin and Pain
| Article | Year |
|---|---|
Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Diflunisal; Femal | 2007 |
A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Arthralgia; Cip | 2021 |
Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
Topics: Adolescent; Anti-Bacterial Agents; Arkansas; Ceftriaxone; Centers for Disease Control and Prevention | 2013 |
Hereditary neuropathy unmasked by levofloxacin.
Topics: Anti-Bacterial Agents; Charcot-Marie-Tooth Disease; Diagnosis, Differential; Family Health; Humans; | 2011 |
Buruli ulcer accompanied by pain in a Japanese patient.
Topics: Anti-Bacterial Agents; Asian People; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Face; | 2012 |
Safety of prolonged high-dose levofloxacin therapy for bone infections.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluati | 2007 |
A 5-year-old girl with headache and eye pain.
Topics: Abducens Nerve Diseases; Anti-Bacterial Agents; Child, Preschool; Cranial Sinuses; Diagnosis, Differ | 2008 |
Changes in white blood cell counts in men undergoing thrice-weekly prostatic massage, microbial diagnosis and antimicrobial therapy for genitourinary complaints.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Antibiotics, Antineoplastic; Bacterial Infections; Drug | 1998 |
[Achilles pain and functional impotence in a patient with chronic obstructive pulmonary disease with pneumonia. Tendon rupture caused by levofloxacin].
Topics: Achilles Tendon; Aged; Anti-Infective Agents; Humans; Levofloxacin; Male; Ofloxacin; Pain; Pneumonia | 2001 |